Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study-Reference-Cited by-同舟云学术

Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study

Published:2023-03 Issue:3 Volume:36 Page:100016
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

Al-Ghamdi Yahya A.^ORCID,Lake Jonathan,Bagg Adam,Thakral Beenu,Wang Sa A.,Bueso-Ramos Carlos,Masarova Lucia,Verstovsek Srdan,Rogers Heesun J.,Hsi Eric D.,Gralewski Jonathon H.,Chabot-Richards Devon,George Tracy I.,Rets Anton,Hasserjian Robert P.,Weinberg Olga K.,Parilla Megan,Arber Daniel A.,Padilla Osvaldo,Orazi Attilio,Tam Wayne

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference25 articles.

1. WHO classification of tumours of haematopoietic and lymphoid tissues;Swerdlow,2017

2. Driver mutations in primary myelofibrosis and their implications;Szuber;Curr Opin Hematol,2018

3. CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons;Tefferi;Leukemia,2014

4. Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients;Tefferi;Am J Hematol,2018

5. Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms;Chang;Med Oncol,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes;Clinical Lymphoma Myeloma and Leukemia;2024-07

2. Momelotinib – a promising advancement in the management of myelofibrosis in adults with anemia;Frontiers in Oncology;2024-06-25

3. Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine;Cancers;2024-04-26

4. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study;American Journal of Clinical Pathology;2024-04-10

5. SETBP1 sets the stage;Blood;2024-04-04